Search results
Results from the WOW.Com Content Network
Sucralose, a chemical found in Splenda, may have cancer-causing properties, a new study finds. Nutritionists offer alternatives to artificial sweeteners. Sucralose, a chemical found in Splenda ...
Various nonnutritive sweeteners have also been linked to heart disease and early death, migraines, depression, dementia, disruptions in gut microbiomes, cancer and cognitive, behavioral and ...
Sucralose is used in many food and beverage products because it is a non-nutritive sweetener (14 kilojoules [3.3 kcal] per typical one-gram serving), [3] does not promote dental cavities, [7] is safe for consumption by diabetics and nondiabetics [8] and does not affect insulin levels. [9]
Routhenstein says that for sweeteners like aspartame, some studies have raised concerns about a link to cancer. However, the majority of research, including reviews by the Food and Drug ...
Multiple reviews have found no link between artificial sweeteners and the risk of cancer. [47] [61] [62] [63] FDA scientists have reviewed scientific data regarding the safety of aspartame and different sweeteners in food, concluding that they are safe for the general population under common intake conditions. [64]
There is no evidence that sweetened beverages are a direct cause of cancer. [36] [37] There is an indirect relationship between sugar-sweetened beverage consumption and increased risk of obesity-related cancers. [38] [39] They are related to cancer risk in their association with excess body weight.
One of the world's most common artificial sweeteners is set to be declared a possible carcinogen next month by a leading global health body, according to two sources with knowledge of the process ...
The artificial sweetener aspartame has been the subject of several controversies since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. The FDA approval of aspartame was highly contested, beginning with suspicions of its involvement in brain cancer, [1] alleging that the quality of the initial research supporting its safety was inadequate and flawed, and that ...